Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

695906.pdf (1.72 MB)

Document type

Article

Version

Published version

Publication date

2019-06-24

Publication license

cc-by (c) Castells, Aina-Alba et al., 2019
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/162604

Discovery of biomarker panels for neural dysfunction in inborn errors of amino acid metabolism.

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1038/s41598-019-45674-2

Abstract

Patients with inborn errors of amino acid metabolism frequently show neuropsychiatric symptoms despite accurate metabolic control. This study aimed to gain insight into the underlying mechanisms of neural dysfunction. Here we analyzed the expression of brain-derived neurotrophic factor (BDNF) and 10 genes required for correct brain functioning in plasma and blood of patients with Urea Cycle Disorders (UCD), Maple Syrup Urine Disease (MSUD) and controls. Receiver-operating characteristic (ROC) analysis was used to evaluate sensitivity and specificity of potential biomarkers. CACNA2D2 (α2δ2 subunit of voltage-gated calcium channels) and MECP2 (methyl-CpG binding protein 2) mRNA and protein showed an excellent neural function biomarker signature (AUC ≥ 0,925) for recognition of MSUD. THBS3 (thrombospondin 3) mRNA and AABA gave a very good biomarker signature (AUC 0,911) for executive-attention deficits. THBS3, LIN28A mRNA, and alanine showed a perfect biomarker signature (AUC 1) for behavioral and mood disorders. Finally, a panel of BDNF protein and at least two large neural AAs showed a perfect biomarker signature (AUC 1) for recognition of psychomotor delay, pointing to excessive protein restriction as central causative of psychomotor delay. To conclude, our study has identified promising biomarker panels for neural function evaluation, providing a base for future studies with larger samples.

Subject

Errors congènits del metabolisme, Aminoàcids, Neuropsiquiatria, Lesions cerebrals

Subject (English)

Inborn errors of metabolism, Amino acids, Neuropsychiatry, Brain damage

Citation

Collections

Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citation

CASTELLS, Aina-Alba, et al. Discovery of biomarker panels for neural dysfunction in inborn errors of amino acid metabolism. Scientific Reports. 2019. Vol. 9, num. 9128. ISSN 2045-2322. [consulted: 9 of August of 2026]. Available at: https://hdl.handle.net/2445/162604

Export metadata

JSON - METS

Share record